Randomized trial of betahistine mesilate tablets as augmentation for oxcarbazepine and carbamazepine in treating vestibular paroxysmia
Hui Xue,1,2 Wenping Xiang,2 Yichuan Yu,3 Guorong Liu,2 Yi Chong,2 Jiying Zhou1 1Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China; 2Department of Neurology, Baotou Central Hospital, Inner Mongolia, Baotou, China; 3Department of Emergency, Yongc...
Main Authors: | Xue H, Xiang W, Yu Y, Liu G, Chong Y, Zhou J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/randomized-trial-of-betahistine-mesilate-tablets-as-augmentation-for-o-peer-reviewed-article-DDDT |
Similar Items
-
A scoping review of vestibular paroxysmia: An acute disabling clinical entity
by: Santosh Kumar Swain, et al.
Published: (2020-01-01) -
Vestibular paroxysmia: Long-term clinical outcome after treatment
by: Chih-Chung Chen, et al.
Published: (2022-10-01) -
Oxcarbazepine: Drug of the future in the treatment of trigeminal neuralgia
by: Revant H Chole, et al.
Published: (2011-01-01) -
Vestibular paroxysmia associated with congenital vascular malformation: A case report
by: Fei Liu, et al.
Published: (2023-03-01) -
The Narrowed Internal Auditory Canal: A Distinct Etiology of Pediatric Vestibular Paroxysmia
by: Samar A. Idriss, et al.
Published: (2022-07-01)